In summary, our study explores the interplay between tumor growth dynamics, lipid metabolism, and NF-κB dysregulation in PM, advancing our understanding of PM pathogenesis, and offering prospects for innovative approaches in the treatment of mesothelioma. This evidence concerns the gene NFKB1 and mesothelioma.